Journal article icon

Journal article

Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases

Abstract:

Objective

To analyze RAPID3, a patient-reported, composite index, designed initially for feasibility in clinical care. RAPID3 was developed in rheumatoid arthritis, but has been found useful in many rheumatic diseases. We analysed RAPID3 in patients with psoriatic arthritis (PsA).

Methods

Post-hoc analyses were performed on two independent datasets, the tight control of PsA (TICOPA) clinical trial, and the long-term outcome in PsA study (LOPAS II), an observation...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1002/acr.23460

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Tillett, W More by this author
Shaddick, G More by this author
Kavanaugh, A More by this author
Expand authors...
National Institute for Health Research More from this funder
Publisher:
Wiley Publisher's website
Journal:
Arthritis Care and Research Journal website
Volume:
70
Issue:
8
Pages:
1198-1205
Publication date:
2017-11-07
Acceptance date:
2017-11-07
DOI:
EISSN:
2151-4658
ISSN:
2151-464X
Pubs id:
pubs:743818
URN:
uri:18dfcaa5-007c-421c-9ea9-41d462805d6e
UUID:
uuid:18dfcaa5-007c-421c-9ea9-41d462805d6e
Local pid:
pubs:743818
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP